Tositumomab/I-131 tositumomab following chemotherapy effective as first-line treatment of NHL

Oncology (Williston Park). 2004 Sep;18(10):1313-4.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Humans
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Neutropenia / chemically induced
  • Prednisone / administration & dosage
  • Referral and Consultation
  • Thrombocytopenia / chemically induced
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Vincristine
  • Cyclophosphamide
  • tositumomab I-131
  • Prednisone